Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.020 AlteredExpression disease BEFREE Vactosertib induced significant regression of fibrotic plaques in PD rats <i>in vivo</i> through reduced infiltration of inflammatory cells and reduced expression of phospho-Smad2, which recovered erectile function. 31496148 2019
Entrez Id: 4015
Gene Symbol: LOX
LOX
0.020 Biomarker disease BEFREE We explored the role of lysyl oxidase (LOX) in rat and human penes after ischemic priapism (IP) to verify the effects of anti-LOX in relieving penile fibrosis and preventing erectile dysfunction caused by IP in rats. 29278308 2018
Entrez Id: 4015
Gene Symbol: LOX
LOX
0.020 Biomarker disease BEFREE This is the 1st study to demonstrate the role of LOX activation in penile fibrosis. 29502979 2018
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.020 Biomarker disease BEFREE IL-6 trans-signaling and PTX3 amplification at the site of inflammation could have a role in pathophysiological mechanisms of PD. 28359407 2017
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.020 AlteredExpression disease BEFREE TGF-β and IL-6 were significantly enhanced in Peyronie's disease. 28721300 2017
Entrez Id: 142
Gene Symbol: PARP1
PARP1
0.020 AlteredExpression disease BEFREE Overexpression of the SMAD7 gene decreased the expression of cyclin D1 (a positive cell cycle regulator) and induced the expression of poly (ADP-ribose) polymerase 1, which is known to terminate Smad-mediated transcription, in PD fibroblasts. 25532569 2016
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.020 AlteredExpression disease BEFREE Overexpression of the SMAD7 gene decreased the expression of cyclin D1 (a positive cell cycle regulator) and induced the expression of poly (ADP-ribose) polymerase 1, which is known to terminate Smad-mediated transcription, in PD fibroblasts. 25532569 2016
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.020 AlteredExpression disease BEFREE We observed that Ad-HDAC2 shRNA decreased inflammatory cell infiltration, reduced transnuclear expression of phospho-Smad3 and regressed fibrotic plaque of the tunica albuginea in PD rats in vivo. siRNA-mediated silencing of HDAC2 significantly decreased the TGF-β1-induced transdifferentiation of fibroblasts into myofibroblasts and collagen production, and induced apoptosis by downregulating the expression of PARP1, and decreased the expression of cyclin D1 (a positive cell-cycle regulator) in primary cultured fibroblasts derived from human PD plaque in vitro. 24841412 2014
Entrez Id: 142
Gene Symbol: PARP1
PARP1
0.020 AlteredExpression disease BEFREE We observed that Ad-HDAC2 shRNA decreased inflammatory cell infiltration, reduced transnuclear expression of phospho-Smad3 and regressed fibrotic plaque of the tunica albuginea in PD rats in vivo. siRNA-mediated silencing of HDAC2 significantly decreased the TGF-β1-induced transdifferentiation of fibroblasts into myofibroblasts and collagen production, and induced apoptosis by downregulating the expression of PARP1, and decreased the expression of cyclin D1 (a positive cell-cycle regulator) in primary cultured fibroblasts derived from human PD plaque in vitro. 24841412 2014
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.020 PosttranslationalModification disease BEFREE Knockdown of HDAC2 in PD fibroblasts abrogated TGF-β1-induced extracellular matrix production by blocking TGF-β1-induced phosphorylation and nuclear translocation of Smad2 and Smad3, and by inhibiting TGF-β1-induced transdifferentiation of fibroblasts into myofibroblasts. 23770939 2013
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.020 AlteredExpression disease BEFREE In conclusion, analysis of MCP-1 expression might be a useful marker for Peyronie's disease. 18704440 2009
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
0.020 Biomarker disease BEFREE Some of the gene families upregulated in both PD and DD were (a) collagen degradation: matrix metalloproteinase (MMP), with MMP2 and MMP9, and thymosins (MMP activators), with TMbeta10 and TMbeta4; (b) ossification: osteoblast-specific factors (OSFs) OSF-1 and OSF-2 (DD only); and (c) myofibroblast differentiation: RhoGDP dissociation inhibitor 1. 15302515 2004
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.020 Biomarker disease BEFREE Some of the gene families upregulated in both PD and DD were (a) collagen degradation: matrix metalloproteinase (MMP), with MMP2 and MMP9, and thymosins (MMP activators), with TMbeta10 and TMbeta4; (b) ossification: osteoblast-specific factors (OSFs) OSF-1 and OSF-2 (DD only); and (c) myofibroblast differentiation: RhoGDP dissociation inhibitor 1. 15302515 2004
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.020 Biomarker disease LHGDN Based on these observations, we propose that MCP-1 could be a novel therapeutic target in PD. 12127997 2002
Entrez Id: 3552
Gene Symbol: IL1A
IL1A
0.010 Biomarker disease BEFREE In vitro model of PD was designed using experimental model of inflammation induced by Interleukin-1 (IL-1) in cultured fibroblasts and mechanical damage of the cells. 31733276 2020
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.010 Biomarker disease BEFREE In vitro model of PD was designed using experimental model of inflammation induced by Interleukin-1 (IL-1) in cultured fibroblasts and mechanical damage of the cells. 31733276 2020
Entrez Id: 7046
Gene Symbol: TGFBR1
TGFBR1
0.010 Biomarker disease BEFREE In view of the critical role of TGF-β and the Smad pathway in the pathogenesis of PD, inhibition of this pathway with an ALK5 inhibitor may represent a novel, targeted therapy for PD. 31496148 2019
Entrez Id: 51564
Gene Symbol: HDAC7
HDAC7
0.010 Biomarker disease BEFREE These findings suggest that specific inhibition of HDAC7 with RNA interference may represent a promising epigenetic therapy for PD. 29706035 2018
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2
0.010 Biomarker disease BEFREE CCH and IFNα-2b injected into stable PD plaques can decrease penile curvature; CCH can also improve penile length. 30237020 2018
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 AlteredExpression disease BEFREE The experiments showed that the protein and messenger RNA levels of α-smooth muscle actin in non-PD TA cells and PD plaque-derived cells were significantly higher in cells exposed to TGF-β1 than those not treated with TGF-β1. 29891411 2018
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.010 GeneticVariation disease BEFREE From January 2007 to January 2015, 60 non-randomized consecutive patients affected by end-stage Peyronie disease underwent PIG and PP implantation (AMS 700CX; Boston Scientific, Marlborough, MA, USA). 29753801 2018
Entrez Id: 136
Gene Symbol: ADORA2B
ADORA2B
0.010 Biomarker disease BEFREE The effect of an ADORA2B agonist on TGF-β1-induced myofibroblast transformation shows a novel potential therapeutic target for PD if applied during early, non-stable phase of PD.Mateus M, Ilg MM, Stebbeds WJ, et al. 29891411 2018
Entrez Id: 5806
Gene Symbol: PTX3
PTX3
0.010 Biomarker disease BEFREE IL-6 trans-signaling and PTX3 amplification at the site of inflammation could have a role in pathophysiological mechanisms of PD. 28359407 2017
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.010 AlteredExpression disease BEFREE The expression of all IGF1 alternative spliced isoforms is decreased in patients with PD, suggestive of its possible participation in the pathophysiology of PD. 27107083 2017
Entrez Id: 3988
Gene Symbol: LIPA
LIPA
0.010 Biomarker disease BEFREE Two senior surgeons (GH, LAL) describe their surgical technique in detail, and provide important aspects and tips one has to be aware of when performing a grafting technique in patients with PD. 28904897 2017